CERENOVUS, part of the Johnson & Johnson Medical Devices, has announced the first patients have been treated with its new EMBOTRAP II Revascularisation Device since it became commercially available in the U.S. EMBOTRAP II is a next generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.

Johnson & Johnson Vision has announced ACUVUE OASYS with Transitions Light Intelligent Technoloy first of its kind contact lens that provides wearers with vision correction and a dynamic photochromic filter that helps to continuously balance the amount of light entering the eye. These contact lenses quickly and seamlessly adjust from clear to dark in response to changing light conditions; reducing exposure to bright light ...